RESMED INC — Director's Dealing 2010

Jul 12, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-07-09

Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-07-09	ResMed Common Stock	M	5000	$38.50	Acquired	8223.897	Direct
2010-07-09	ResMed Common Stock	S	5000	$65.00	Disposed	3223.897	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-07-09	ResMed Common Stock Options	$38.50	M	5000	Disposed	2016-02-03	ResMed Common Stock (5000)	Direct

Footnotes

F1: Represents first date options became exercisable.

F2: Trade executed in accordance with 10b5-1 trading program.